Decision-support for treatment with (177)Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parameters

BACKGROUND: Treatment with radiolabeled ligands to prostate-specific membrane antigen (PSMA) is gaining importance in the treatment of patients with advanced prostate carcinoma. Previous imaging with positron emission tomography/computed tomography (PET/CT) is mandatory. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Moazemi, Sobhan, Erle, Annette, Khurshid, Zain, Lütje, Susanne, Muders, Michael, Essler, Markus, Schultz, Thomas, Bundschuh, Ralph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article on Artificial Intelligence in Molecular Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246232/
https://www.ncbi.nlm.nih.gov/pubmed/34268431
http://dx.doi.org/10.21037/atm-20-6446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246232/
https://www.ncbi.nlm.nih.gov/pubmed/34268431
http://dx.doi.org/10.21037/atm-20-6446

Ejemplares similares